Twelve patients (22.2%) discontinued GLP-1 treatment due to side effects, which included gastrointestinal symptoms (n = 14), dizziness (n = 1), and depression (n = 1) and an allergic reaction in one patient. This evidence concerns the gene GLP1R and depressive disorder.